Connect with execs from The New York Times, TIME, Dotdash Meredith and many more
Mushroom boardroom: Why some execs are using psychedelics to get through the workday

This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing

Generative AI sparks brand safety concerns marketers know all too well
Despite concerns around brand misuse and IP, most marketers are sticking to traditional strategies.

‘Production is a big topic right now’: With AI moving beyond media, Publicis turns toward creative
The holdco is positioning AI as core infrastructure for ad production not just media buys.

Instagram offers a new guide to advertisers to convince them to try out its creator marketplace
The 26-page document aims to make the whole process quick and painless.